http://orcid.org/0000-0002-6497-1012
Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Hanine Rafidi, Sharmila Rajan, Konnie Urban, Whitney Shatz-Binder, Keliana Hui, Gregory Z. Ferl, Amrita V. Kamath & C. Andrew Boswell. (2022) Effect of molecular size on interstitial pharmacokinetics and tissue catabolism of antibodies. mAbs 14:1.
Read now
Read now
Rachel H. Rose, Armin Sepp, Felix Stader, Katherine L. Gill, Cong Liu & Iain Gardner. (2022) Application of physiologically based pharmacokinetic models for therapeutic proteins and other novel modalities. Xenobiotica 52:8, pages 840-854.
Read now
Read now
Charlotte Bon, Thomas Hofer, Alain Bousquet-Mélou, Mark R. Davies & Ben-Fillippo Krippendorff. (2017) Capacity limits of asialoglycoprotein receptor-mediated liver targeting. mAbs 9:8, pages 1360-1369.
Read now
Read now
Articles from other publishers (43)
Yunda Huang, Lily Zhang, Shelly Karuna, Philip Andrew, Michal Juraska, Joshua A. Weiner, Heather Angier, Evgenii Morgan, Yasmin Azzam, Edith Swann, Srilatha Edupuganti, Nyaradzo M. Mgodi, Margaret E. Ackerman, Deborah Donnell, Lucio Gama, Peter L. Anderson, Richard A. Koup, John Hural, Myron S. Cohen, Lawrence Corey, M. Juliana McElrath, Peter B. Gilbert & Maria P. Lemos. (2023) Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01. Nature Communications 14:1.
Crossref
Crossref
Simon Huet, Magali Zeisser Labouebe, Rute Castro, Perrine Jacquot, Jessy Pedrault, Sébastien Viollet, Gaetan Van Simaeys, Gilles Doumont, Lionel Larbanoix, Egor Zindy, António E. Cunha, Leonardo Scapozza & Mathieu Cinier. (2023) Targeted Nanofitin-drug Conjugates Achieve Efficient Tumor Delivery and Therapeutic Effect in an EGFRpos Mouse Xenograft Model. Molecular Cancer Therapeutics 22:11, pages 1343-1351.
Crossref
Crossref
Linda Schellhammer, Michal Beffinger, Ulisse Salazar, Jon D. Laman, Thorsten Buch & Johannes vom Berg. (2023) Exit pathways of therapeutic antibodies from the brain and retention strategies. iScience 26:11, pages 108132.
Crossref
Crossref
Martin R. Edelmann, Christoph Bredack, Sara Belli, Peter Mohr, Marie-Paule Imhoff, Flore Reggiani, Eric A. Kusznir, Arne C. Rufer, Daniel P. Holt, Heather Valentine, Dean F. Wong, Robert F. Dannals, Michael Honer & Luca C. Gobbi. (2023) Evaluation of Tetrazine Tracers for Pretargeted Imaging within the Central Nervous System. Bioconjugate Chemistry 34:10, pages 1882-1893.
Crossref
Crossref
Thinzar M. Lwin, Megan Minnix, Lin Li, Anakim Sherman, Teresa Hong, Jeffery Y. C. Wong, Tove Olafsen, Erasmus Poku, Michael Bouvet, Yuman Fong, John E. Shively & Paul J. Yazaki. (2023) Multimodality PET and Near-Infrared Fluorescence Intraoperative Imaging of CEA-Positive Colorectal Cancer. Molecular Imaging and Biology 25:4, pages 727-734.
Crossref
Crossref
William M. Pardridge. (2023) Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier. Frontiers in Drug Delivery 3.
Crossref
Crossref
Miho Nagayasu, Yoko Takano & Kazuhisa Ozeki. (2023) Development of a New Method to Evaluate the Biodistribution of Antibodies Using Non-Radioactive Metal Labeling and Inductively Coupled Plasma Mass Spectrometry. Pharmaceutical Research 40:7, pages 1807-1819.
Crossref
Crossref
H. Adams, E. M. W. van de Garde, D. J. Vugts, J. C. Grutters, Wim. J.G. Oyen & R. G. Keijsers. (2023) [89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial. European Journal of Nuclear Medicine and Molecular Imaging 50:7, pages 1929-1939.
Crossref
Crossref
Gibran Nasir & Photini Sinnis. (2023) Transport of antibody into the skin is only partially dependent upon the neonatal Fc-receptor. PLOS ONE 18:4, pages e0273960.
Crossref
Crossref
N. Stergiou, T. E. Wuensche, M. Schreurs, I. Mes, M. Verlaan, E. J. M. Kooijman, A. D. Windhorst, L. Helboe, S. Vergo, S. Christensen, A. A. Asuni, A. Jensen, G. A. M. S. Van Dongen, B. Bang-Andersen, D. J. Vugts & W. Beaino. (2023) Application of 89Zr-DFO*-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-ß monoclonal antibody. European Journal of Nuclear Medicine and Molecular Imaging 50:5, pages 1306-1317.
Crossref
Crossref
Saikat Ghosh, Nicholas L. Fletcher, Pie Huda, Zachary H. Houston, Christopher B. Howard, Maria E. Lund, Yanling Lu, Douglas H. Campbell, Bradley J. Walsh & Kristofer J. Thurecht. (2023)
Pharmacokinetics and Biodistribution of
89
Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma
. Molecular Pharmaceutics 20:3, pages 1549-1563.
Crossref
Crossref
Jill Barber, Zubida M. Al-Majdoub, Narciso Couto, Martyn Howard, Yasmine Elmorsi, Daniel Scotcher, Naved Alizai, Saskia de Wildt, Felix Stader, Armin Sepp, Amin Rostami-Hodjegan & Brahim Achour. (2023) Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc Receptor (FcRn) in human tissues and implications for pharmacokinetic modelling. European Journal of Pharmaceutical Sciences 182, pages 106375.
Crossref
Crossref
Martin R. Edelmann. (2022) Radiolabelling small and biomolecules for tracking and monitoring. RSC Advances 12:50, pages 32383-32400.
Crossref
Crossref
Arthur J. Van De Vyver, Antje-Christine Walz, Mariette S. Heins, Afsaneh Abdolzade-Bavil, Thomas E. Kraft, Inja Waldhauer & Michael B. Otteneder. (2022) Investigating brain uptake of a non-targeting monoclonal antibody after intravenous and intracerebroventricular administration. Frontiers in Pharmacology 13.
Crossref
Crossref
Kenta Haraya, Haruka Tsutsui, Yasunori Komori & Tatsuhiko Tachibana. (2022) Recent Advances in Translational Pharmacokinetics and Pharmacodynamics Prediction of Therapeutic Antibodies Using Modeling and Simulation. Pharmaceuticals 15:5, pages 508.
Crossref
Crossref
Jakob C. Stüber, Karin F. Rechberger, Saša M. Miladinović, Thomas Pöschinger, Tamara Zimmermann, Remi Villenave, Miro J. Eigenmann, Thomas E. Kraft, Dhaval K. Shah, Hubert Kettenberger & Wolfgang F. Richter. (2022) Impact of charge patches on tumor disposition and biodistribution of therapeutic antibodies. AAPS Open 8:1.
Crossref
Crossref
Bernd Meibohm. (2022) Knowledge Gaps in the Pharmacokinetics of Therapeutic Proteins in Pediatric Patients. Frontiers in Pharmacology 13.
Crossref
Crossref
Paul R. V. Malik, Abdullah Hamadeh & Andrea N. Edginton. (2022) Model-Based Assessment of the Contribution of Monocytes and Macrophages to the Pharmacokinetics of Monoclonal Antibodies. Pharmaceutical Research 39:2, pages 239-250.
Crossref
Crossref
Molly Brady, Conor McQuaid, Alexander Solorzano, Angelique Johnson, Abigail Combs, Chethana Venkatraman, Akib Rahman, Hannah Leyva, Wing-Chi Edmund Kwok, Ronald W. Wood & Rashid Deane. (2021) Spike protein multiorgan tropism suppressed by antibodies targeting SARS-CoV-2. Communications Biology 4:1.
Crossref
Crossref
Martin R. Edelmann & Simon Hauri. (2021) Functional in vitro assessment of modified antibodies: Impact of label on protein properties. PLOS ONE 16:9, pages e0257342.
Crossref
Crossref
Alyssa Marie M. Castillo, Trang T. Vu, Sophia G. Liva, Min Chen, Zhiliang Xie, Justin Thomas, Bryan Remaily, Yizhen Guo, Uma L. Subrayan, Travis Costa, Timothy H. Helms, Donald J. Irby, Kyeongmin Kim, Dwight H. Owen, Samuel K. Kulp, Thomas A. Mace, Mitch A. Phelps & Christopher C. Coss. (2021) Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humans. JCSM Rapid Communications 4:2, pages 232-244.
Crossref
Crossref
Aida Kouhi, Vyshnavi Pachipulusu, Talya Kapenstein, Peisheng Hu, Alan L. Epstein & Leslie A. Khawli. (2021) Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and Perspectives. International Journal of Molecular Sciences 22:12, pages 6442.
Crossref
Crossref
Sheena N. Smith, Rajib Schubert, Branko Simic, Dominik Brücher, Markus Schmid, Niels KirkPatrick C. Freitag, Viviana Gradinaru & Andreas Plückthun. (2021) The SHREAD gene therapy platform for paracrine delivery improves tumor localization and intratumoral effects of a clinical antibody. Proceedings of the National Academy of Sciences 118:21.
Crossref
Crossref
Nicholas Cho, Sooah Ko & Monica Shokeen. (2020) Preclinical Development of Near-Infrared-Labeled CD38-Targeted Daratumumab for Optical Imaging of CD38 in Multiple Myeloma. Molecular Imaging and Biology 23:2, pages 186-195.
Crossref
Crossref
Timothy Qi & Yanguang Cao. (2021) In Translation: FcRn across the Therapeutic Spectrum. International Journal of Molecular Sciences 22:6, pages 3048.
Crossref
Crossref
Hsuan-Ping Chang, Se Jin Kim & Dhaval K. Shah. (2021) Whole-Body Pharmacokinetics of Antibody in Mice Determined using Enzyme-Linked Immunosorbent Assay and Derivation of Tissue Interstitial Concentrations. Journal of Pharmaceutical Sciences 110:1, pages 446-457.
Crossref
Crossref
Xiazi Qiu & Michael Zhuo Wang. (2020) Quantification of Neonatal Fc Receptor and Beta-2 Microglobulin in Human Liver Tissues by Ultraperformance Liquid Chromatography–Multiple Reaction Monitoring–based Targeted Quantitative Proteomics for Applications in Biotherapeutic Physiologically-based Pharmacokinetic Models. Drug Metabolism and Disposition 48:10, pages 925-933.
Crossref
Crossref
Robert J Oldham, C Ian Mockridge, Sonya James, Patrick J Duriez, H T Claude Chan, Kerry L Cox, Vicentiu A Pitic, Martin J Glennie & Mark S Cragg. (2020) FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion. Journal for ImmunoTherapy of Cancer 8:1, pages e000619.
Crossref
Crossref
Taiki Kurino, Reiko Matsuda, Ayu Terui, Hiroyuki Suzuki, Tomomi Kokubo, Tomoya Uehara, Yasushi Arano, Akihiro Hisaka & Hiroto Hatakeyama. (2020) Poor outcome with anti-programmed death-ligand 1 (PD-L1) antibody due to poor pharmacokinetic properties in PD-1/PD-L1 blockade-sensitive mouse models. Journal for ImmunoTherapy of Cancer 8:1, pages e000400.
Crossref
Crossref
Yvonne W.S. Jauw, Joseph A. O’Donoghue, Josée M. Zijlstra, Otto S. Hoekstra, C. Willemien Menke-van der Houven van Oordt, Franck Morschhauser, Jorge A. Carrasquillo, Sonja Zweegman, Neeta Pandit-Taskar, Adriaan A. Lammertsma, Guus. A.M.S. van Dongen, Ronald Boellaard, Wolfgang A. Weber & Marc C. Huisman. (2019)
89
Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo
. Journal of Nuclear Medicine 60:12, pages 1825-1832.
Crossref
Crossref
Martin R. Edelmann, Hubert Kettenberger, Alexander Knaupp, Tilman Schlothauer & Michael B. Otteneder. (2019) Radiolabeled IgG antibodies: Impact of various labels on neonatal Fc receptor binding. Journal of Labelled Compounds and Radiopharmaceuticals 62:11, pages 751-757.
Crossref
Crossref
Yao-Yun Fan, Vahid Farrokhi, Teresa Caiazzo, Mengmeng Wang, Denise M. O’Hara & Hendrik Neubert. (2019) Human FcRn Tissue Expression Profile and Half-Life in PBMCs. Biomolecules 9:8, pages 373.
Crossref
Crossref
Armin Sepp, Guy Meno-Tetang, Andrew Weber, Andrew Sanderson, Oliver Schon & Alienor Berges. (2019) Computer-assembled cross-species/cross-modalities two-pore physiologically based pharmacokinetic model for biologics in mice and rats. Journal of Pharmacokinetics and Pharmacodynamics 46:4, pages 339-359.
Crossref
Crossref
Michal Pyzik, Kine M. K. Sand, Jonathan J. Hubbard, Jan Terje Andersen, Inger Sandlie & Richard S. Blumberg. (2019) The Neonatal Fc Receptor (FcRn): A Misnomer?. Frontiers in Immunology 10.
Crossref
Crossref
Mohammad Tabrizi, Divas Neupane, Sophia E. Elie, Harish Shankaran, Veronica Juan, Shuli Zhang, SuChun Hseih, Laurence Fayadat-Dilman, Daping Zhang, Yaoli Song, Vaishnavi Ganti, Michael Judo, Daniel Spellman, Wolfgang Seghezzi & Enrique Escandon. (2019) Pharmacokinetic Properties of Humanized IgG1 and IgG4 Antibodies in Preclinical Species: Translational Evaluation. The AAPS Journal 21:3.
Crossref
Crossref
Patrick M. Glassman & Joseph P. Balthasar. (2019) Physiologically-based modeling of monoclonal antibody pharmacokinetics in drug discovery and development. Drug Metabolism and Pharmacokinetics 34:1, pages 3-13.
Crossref
Crossref
Hanne Haslene-Hox. (2019) Measuring gradients in body fluids – A tool for elucidating physiological processes, diagnosis and treatment of disease. Clinica Chimica Acta 489, pages 233-241.
Crossref
Crossref
Andrew T. Lucas, Ryan Robinson, Allison N. Schorzman, Joseph A. Piscitelli, Juan F. Razo & William C. Zamboni. (2019) Pharmacologic Considerations in the Disposition of Antibodies and Antibody-Drug Conjugates in Preclinical Models and in Patients. Antibodies 8:1, pages 3.
Crossref
Crossref
Bernd Meibohm. 2019. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology
105
137
.
Weston J. Smith, Guankui Wang, Hanmant Gaikwad, Vivian P. Vu, Ernest Groman, David W. A. Bourne & Dmitri Simberg. (2018) Accelerated Blood Clearance of Antibodies by Nanosized Click Antidotes. ACS Nano 12:12, pages 12523-12532.
Crossref
Crossref
Mengxin Xu, Yuxiang Han, Guizhong Liu, Yang Xu, Dongban Duan, Hui Liu, Felix Du, Peter Luo & Zhibo Liu. (2018) Preclinical Study of a Fully Human Anti-PD-L1 Antibody as a Theranostic Agent for Cancer Immunotherapy. Molecular Pharmaceutics 15:10, pages 4426-4433.
Crossref
Crossref
Alexander G. J. Skorput, Xijing Zhang, Jonathan J. Waataja, Cristina D. Peterson, Maureen S. Riedl, Kelley F. Kitto, Hai Truong, Cecilia Huffman, Stephen R. Salton, Carolyn A. Fairbanks, Christopher N. Honda & Lucy Vulchanova. (2018) Involvement of the VGF-derived peptide TLQP-62 in nerve injury–induced hypersensitivity and spinal neuroplasticity. Pain 159:9, pages 1802-1813.
Crossref
Crossref
Miro J. Eigenmann, Tine V. Karlsen, Ben‐Fillippo Krippendorff, Olav Tenstad, Ludivine Fronton, Michael B. Otteneder & Helge Wiig. (2017)
Interstitial IgG antibody pharmacokinetics assessed by combined
in vivo
‐ and physiologically‐based pharmacokinetic modelling approaches
. The Journal of Physiology 595:24, pages 7311-7330.
Crossref
Crossref